MoneyWorks4Me

Godavari Drugs - Quaterly Results

19 Apr 2022 Evaluate
The sales surged to Rs. 442.80 millions, up 34.35% for the March 2022 quarter as against Rs. 329.58 millions during the corresponding quarter previous year.Net profit declined -1.48% to Rs. 12.67 millions from Rs. 12.86 millions.Operating profit surged to 28.20 millions from the corresponding previous quarter of 26.81 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 442.80 329.58 34.35 1611.06 1226.70 31.33 1611.06 1226.70 31.33
Other Income 1.16 1.14 1.75 2.76 4.10 -32.68 2.76 4.10 -32.68
PBIDT 28.20 26.81 5.18 115.66 102.50 12.84 115.66 102.50 12.84
Interest 6.18 8.11 -23.80 28.49 33.21 -14.21 28.49 33.21 -14.21
PBDT 22.02 18.70 17.75 87.17 69.29 25.80 87.17 69.29 25.80
Depreciation 4.20 3.75 12.00 16.96 12.23 38.68 16.96 12.23 38.68
PBT 17.82 14.95 19.20 70.21 57.06 23.05 70.21 57.06 23.05
TAX 5.15 2.09 146.41 17.75 15.78 12.48 17.75 15.78 12.48
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 12.67 12.86 -1.48 52.46 41.28 27.08 52.46 41.28 27.08
Equity 75.31 75.31 0.00 75.31 75.31 0.00 75.31 75.31 0.00
PBIDTM(%) 6.37 8.13 -21.71 7.18 8.36 -14.08 7.18 8.36 -14.08
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..